THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet
Abstract Background Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, diabetes, and dyslipidemia. Several studies in mice and humans have implicated the involvement of the gut microbiome in NAFLD. While cannabis and its phytocannabinoids ma...
Main Authors: | Jonathan Gorelick, Tal Assa-Glazer, Gil Zandani, Anna Altberg, Noa Sela, Abraham Nyska, Zecharia Madar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Journal of Cannabis Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42238-022-00137-w |
Similar Items
-
The Impact of THC and CBD in Schizophrenia: A Systematic Review
by: Saeed Ahmed, et al.
Published: (2021-07-01) -
Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial
by: Sukpiriyagul A, et al.
Published: (2023-08-01) -
Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice
by: Nichole Reisdorph, et al.
Published: (2024-03-01) -
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
by: Nicholas Pintori, et al.
Published: (2023-03-01) -
<i>Cannabis sativa</i> L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
by: Anna Stasiłowicz, et al.
Published: (2021-01-01)